Understanding Cannabinoids: CBN vs CBD
While there are many cannabinoids that may enhance the therapeutic effects of hemp products, the most common renowned product is the phytochemicals in the Cannabis genus that contain the tetrahydrocannabinol or THC. This is the substance that is responsible for all of the psychoactive effects of cannabis. CBD has long been associated with the variety that offers up the best help benefits without offering up the high that the THC gives to users.
While the CBD may not be the feature that is in all of the hemp products, it’s a by-product of the THC. Hemp Genix, Wholesale CBD Oil in Latta, has 80% purity compared to competitors at 17%-40%. The CBN doesn’t bind to the body’s cannabinoid receptors like the THC does. It’s long been known to give a stronger sedative effect when it’s used in combination with the THC.
At Hemp Genix, all of our products are made with 100 percent USA, Zero THC and 80 percent purity Wholesale full-spectrum CBD oil in Latta. This is carefully derived from a variety of cultivars of hemp which contain an abundance of cannabinoids.
A lot of people are very familiar with CBD or Cannabidiol. This is found in highly concentrated amounts in a variety of products. However, there are lots of cannabinoids that are found in hemp. These have shown a variety of benefits in studies. All of our products offer you full-spectrum hemp oil. This also includes all of our cannabinoids that are found in the plant. We don’t want you to miss out on any of the benefits.
Wholesale Cannabidiol CBD in Latta
This is the most abundant cannabinoid in the hemp oil. It makes up 90 percent of the content of cannabinoid. It’s non-psychoactive and the focus is on how it benefits the body via the hemp oil. It has minimal affinity for CB1 or CB2 receptors. The main focus on interaction is in the endocannabinoid system and it acts as an indirect antagonist toward the cannabinoid antagonists. This, in turn, may allow the CBD to temper the high that is caused through the THC. Wholesale CBD Oil in Latta from Hemp Genix are over 80 percent pure and CBD makes up the majority of the Oils weight. Industry averages and nearly all of the other products with cannabinoids and brands average in at 17 to 40 percent purity.
What’s The Difference Between CBD And CBN?
Cannabis has a number of cannabinoids in which the most abundant are the levels of THC. There are 9 tetrahydrocannabinol as well as CBD and CBN. This is the active ingredient that makes you high. The THC is in the plant and the CBD is the precursor and the CBN is the metabolite of the THC. As the cannabis ages, the THC level breaks down into the CBN.
This also leads researchers to believe that the CBD might give some protection against ecstasy-derived neurotoxins or long-term depletion of the serotonergic receptions. While this is still speculation, it’s investigating further. The CBD is usually present in significant enough quantities in such products as hashish or cannabis resins. However,r it’s also in the herbal cannabis referred to as skunk in smaller amounts.
Overall, the CBN is a great cannabinoid that offers up a varied range of therapeutic applications that work together with the rest of the “team” in order to offer up the best possible results. Clearly, more clinical trials are required to see how else it can benefit patients.
Wholesale CBD Oil in Latta South Carolina
Almost all U.S. voters support medical marijuana if prescribed by a doctor, a new Quinnipiac University National poll finds.
The poll, which was released Monday, finds that 89 percent of U.S. voters support allowing adults to legally use marijuana for medical purposes if prescribed by a doctor. Medical marijuana is a nonpartisan issue, the poll finds, with 81 percent of Republicans, 94 percent of Democrats, and 93 percent of Independent voters all say medical pot should be legal.
Such growing support bodes well for the industry despite its murky legal status in the U.S. Already 24 states and the District of Columbia have sanctioned some form of the plant's medicinal or recreational uses.
The poll also found that 87 percent U.S. voters believe that U.S. Veterans Administration doctors should be allowed to prescribe medical marijuana in pill form to veterans suffering from Post Traumatic Stress Disorder in states where cannabis is legal.
When asked more generally, should the use of marijuana be made legal in the United States, 54 percent of voters said yes. Out of that group, 36 percent of Republicans support legalization (62 percent don't support legalization), 65 percent of Democrats and 61 percent of Independents said "yes" to legalization. When it comes to men and women, they voted 60 percent and 48 percent in favor of legalization, respectively.
The Quinnipiac University Poll surveyed 1,561 registered voters nationwide between May 24-30, 2016 with a margin of error of plus or minus 2.5 percentage points.
Voter attitudes towards marijuana have changed dramatically over the years. Back in 1969, Gallup found only 12 percent of Americans surveyed favored legalization. In 2013, a Gallup poll found 58 percent of Americans support legalization.
The Quinnipiac voters' poll finds that the majority of eligible voters are pro pot for medical purposes and in general.
Tom Angell, the chair of pro-legalization group Marijuana Majority, says this newest poll goes to show that cannabis reform is a mainstream issue that is supported by most Americans. Angell says with up to 10 states voting on marijuana legalization at the ballot box this November, he expects to see more states to implement their own state-sanctioned industries.
"This is just the latest in a string of recent polls clearly showing that most voters support legalizing marijuana," Angell says. "These results and similar ones before them are exactly why, for the first time ever, every remaining presidential candidate has voiced support for letting states legalize marijuana without federal interference."
Here's Why Some Cannabis Farmers Will Vote No On the Recreational Pot Ballot in California
In a historic move, the U.S. Drug Enforcement Agency granted approval for a nonprofit to study marijuana's medical benefits on military veterans suffering from combat-related psychological disorders.
The Multidisciplinary Association for Psychedelic Studies (MAPS), a California-based nonprofit that studies medical uses of psychotropic drugs, will conduct the clinical trial, which will be a double-blind, placebo-controlled trial using the whole plant (not an extract or pill version). The trial is the first in U.S. history to receive full approval from the DEA and FDA.
The study will examine whether medical marijuana can treat Post-Traumatic Stress Disorder in 76 U.S. military veterans. The veterans have treatment-resistant PTSD and haven't found relief from other medications. The study will look into how different strains and doses of marijuana can benefit the veterans and look into potential side effects, a press release from MAPS says.
The trial intends to develop "smoked botanical marijuana into a legal prescription drug" approved by the FDA, MAPS says in a statement.
MAPS received a $2.16 million grant from Colorado's Department of Public Health and Environment (CDPHE) to conduct the trial.
"We have been working towards approval since we opened the Investigational New Drug Application (IND) with the FDA in 2010," said Amy Emerson, executive director and director of clinical research for the MAPS Public Benefit Corporation, in a release. "We are thrilled to see this study overcome the hurdles of approval so we can begin gathering the data. This study is a critical step in moving our botanical drug development program forward at the federal level to gather information on the dosing, risks, and benefits of smoked marijuana for PTSD symptoms."
MAPS, which was founded in 1986, has raised over $36 million for psychedelic therapy and research and education in marijuana's medical benefits.